FARON PHARMACEUTICALS OY
Clinical-stage biopharmaceutical company developing immunotherapies for cancer.
FARN | IL
Overview
Corporate Details
- ISIN(s):
- FI4000153309
- LEI:
- 7437009H31TO1DC0EB42
- Country:
- Finland
- Address:
- Joukahaisenkatu 6, FI-20520 TURKU
- Website:
- https://faron.com/
- Sector:
- Manufacturing
Description
Faron Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer. The company pioneers macrophage-targeting therapies to leverage the patient's immune system, aiming to address unmet medical needs and improve outcomes. Its lead asset, bexmarilimab, is a first-in-class anti-Clever-1 antibody and a myeloid cell-targeting immunotherapy candidate. Bexmarilimab is being investigated in clinical trials as a potential therapy for hematological malignancies and solid tumors, often in combination with standard-of-care treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-22 08:00 |
Faron announces strategic collaboration with The Institute for Cancer Research …
|
English | 10.7 KB | ||
| 2025-12-17 15:30 |
Composition of Faron Pharmaceutical’s Shareholders’ Nomination Board
|
English | 6.5 KB | ||
| 2025-12-11 09:30 |
Faron issues second tranche of bonds with an aggregated principal amount of EUR…
|
English | 20.4 KB | ||
| 2025-12-08 08:00 |
Faron presents updated BEXMAB data at ASH 2025: Deep and durable responses in H…
|
English | 14.4 KB | ||
| 2025-12-04 17:00 |
Faron Pharmaceuticals Ltd: Holding(s) in Company
|
English | 49.6 KB | ||
| 2025-12-03 11:00 |
Faron Pharmaceuticals Ltd: Registration of New Shares
|
English | 7.5 KB | ||
| 2025-12-03 08:00 |
Faron Pharmaceuticals Ltd: Approval of Share Subscriptions Based on Special Rig…
|
English | 12.7 KB | ||
| 2025-12-02 08:00 |
Faron Pharmaceuticals Ltd: Grant of Options
|
English | 25.1 KB | ||
| 2025-12-01 08:00 |
Faron Pharmaceuticals Ltd: Appointment of CFO
|
English | 8.5 KB | ||
| 2025-11-27 08:00 |
Faron’s Financial Calendar for 2026
|
English | 7.5 KB | ||
| 2025-11-24 18:15 |
INSIDE INFORMATION: FARON INTENDS TO ISSUE SECOND TRANCHE OF BONDS WITH AN AGGR…
|
English | 13.5 KB | ||
| 2025-11-04 08:00 |
Faron announces two bexmarilimab abstracts accepted at ASH 2025, including an o…
|
English | 11.5 KB | ||
| 2025-11-03 08:00 |
Faron hits key milestone with BEXMAB Phase 2 completion, advances to registrati…
|
English | 9.6 KB | ||
| 2025-10-28 08:00 |
Faron Pharmaceuticals Ltd: Approval of Share Subscriptions Based on Special Rig…
|
English | 10.2 KB | ||
| 2025-10-21 15:10 |
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
|
English | 49.7 KB |
Automate Your Workflow. Get a real-time feed of all FARON PHARMACEUTICALS OY filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for FARON PHARMACEUTICALS OY
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for FARON PHARMACEUTICALS OY via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
